Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02714842Phase 1Completed
Phase 1, randomised, open-label trial of diclofenac in pain (4 arms), sponsored by BDD Pharma. Primary endpoints: Gastric Emptying Time at 16 hours, Small Intestinal Transit Time at 16 hours and 1 more. Started Mar 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02714842.